Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2015 1
2016 1
2017 2
2019 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
Samadder NJ, Foster N, McMurray RP, Burke CA, Stoffel E, Kanth P, Das R, Cruz-Correa M, Vilar E, Mankaney G, Buttar N, Thirumurthi S, Turgeon DK, Sossenheimer M, Westover M, Richmond E, Umar A, Della'Zanna G, Rodriguez LM, Szabo E, Zahrieh D, Limburg PJ. Samadder NJ, et al. Among authors: della zanna g. Gut. 2023 Feb;72(2):256-263. doi: 10.1136/gutjnl-2021-326532. Epub 2022 May 30. Gut. 2023. PMID: 35636921 Free PMC article. Clinical Trial.
Clinical Study of Ursodeoxycholic Acid in Barrett's Esophagus Patients.
Banerjee B, Shaheen NJ, Martinez JA, Hsu CH, Trowers E, Gibson BA, Della'Zanna G, Richmond E, Chow HH. Banerjee B, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2016 Jul;9(7):528-33. doi: 10.1158/1940-6207.CAPR-15-0276. Epub 2016 Feb 23. Cancer Prev Res (Phila). 2016. PMID: 26908564 Free PMC article. Clinical Trial.
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
Sinicrope FA, Viggiano TR, Buttar NS, Song LMWK, Schroeder KW, Kraichely RE, Larson MV, Sedlack RE, Kisiel JB, Gostout CJ, Kalaiger AM, Patai ÁV, Della'Zanna G, Umar A, Limburg PJ, Meyers JP, Foster NR, Yang CS, Sontag S. Sinicrope FA, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2021 May;14(5):573-580. doi: 10.1158/1940-6207.CAPR-20-0598. Epub 2021 Mar 1. Cancer Prev Res (Phila). 2021. PMID: 33648940 Free PMC article. Clinical Trial.
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.
Weinberg DS, Foster NR, Della'Zanna G, McMurray RP, Kraft WK, Pallotto A, Kastenberg DM, Katz LC, Henry CH, Moleski SM, Limburg PJ, Waldman SA. Weinberg DS, et al. Among authors: della zanna g. Cancer Biol Ther. 2021 Dec 2;22(10-12):544-553. doi: 10.1080/15384047.2021.1967036. Epub 2021 Oct 10. Cancer Biol Ther. 2021. PMID: 34632925 Free PMC article. Clinical Trial.
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
Weinberg DS, Lin JE, Foster NR, Della'Zanna G, Umar A, Seisler D, Kraft WK, Kastenberg DM, Katz LC, Limburg PJ, Waldman SA. Weinberg DS, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2017 Jun;10(6):345-354. doi: 10.1158/1940-6207.CAPR-16-0286. Epub 2017 Apr 10. Cancer Prev Res (Phila). 2017. PMID: 28396341 Free PMC article. Clinical Trial.
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, Skripkauskas S, Page K, Weber CR, Huang X, Richmond E, Bergan RC, Backman V. Roy HK, et al. Among authors: della zanna g. Gut. 2017 Feb;66(2):285-292. doi: 10.1136/gutjnl-2015-309996. Epub 2015 Oct 26. Gut. 2017. PMID: 26503631 Free PMC article. Clinical Trial.
Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
Sinicrope FA, Velamala PR, Song LMWK, Viggiano TR, Bruining DH, Rajan E, Gostout CJ, Kraichely RE, Buttar NS, Schroeder KW, Kisiel JB, Larson MV, Sweetser SR, Sedlack RR, Sinicrope SN, Richmond E, Umar A, Della'Zanna G, Noaeill JS, Meyers JP, Foster NR. Sinicrope FA, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2019 Nov;12(11):821-830. doi: 10.1158/1940-6207.CAPR-19-0167. Epub 2019 Sep 4. Cancer Prev Res (Phila). 2019. PMID: 31484660 Clinical Trial.
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasms.
Lipkin S, Lee J, Imagawa D, Hewitt SM, Tucker C, Zell JA, Wong V, Garcia A, Gonzalez R, Della Zanna G, Richmond E, Rodriguez LM, Bigg M, Schnoll-Sussmans F, Meyskens F. Lipkin S, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2011 Apr;4(4):512-3. doi: 10.1158/1940-6207.CAPR-10-0373. Cancer Prev Res (Phila). 2011. PMID: 21464031 Free PMC article. Clinical Trial.
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
Limburg PJ, Mahoney MR, Ziegler KL, Sontag SJ, Schoen RE, Benya R, Lawson MJ, Weinberg DS, Stoffel E, Chiorean M, Heigh R, Levine J, Della'Zanna G, Rodriguez L, Richmond E, Gostout C, Mandrekar SJ, Smyrk TC; Cancer Prevention Network. Limburg PJ, et al. Among authors: della zanna g. Cancer Prev Res (Phila). 2011 Feb;4(2):259-69. doi: 10.1158/1940-6207.CAPR-10-0215. Epub 2011 Jan 5. Cancer Prev Res (Phila). 2011. PMID: 21209397 Free PMC article. Clinical Trial.
11 results